USD0.000æéå€ååŒÂ  (ET)
23.94MæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
äž»èŠããŒã¿
2.160å§å€
2.250é«å€
73.17Kåºæ¥é«
æå€±é¡çŽè¿12ã¶æPER
æå€±é¡äºæ³PER
--çŽè¿12ã¶æé
åœ
0.68%売買å転ç
2.150忥çµå€
2.130å®å€
126.90K売買代é
æå€±é¡æ ªäŸ¡åçç
0.68PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-28.93%ç·è³ç£å©çç
3.06552é±é«å€
2.75åºæ¥é«æ¯ç%
-13.56MçŽå©ç
10.73Mæ ªåŒæ°
-4.60801æ ªåœããå©çïŒEPSïŒ
0.25ããŒã¿å€
-97.42%èªå·±è³æ¬å©çç
1.46052é±å®å€
5.58%æ¯ãå¹
55.10%ç²å©çç
23.94MæäŸ¡ç·é¡
-0.14ãªã¹ã¯ãªã¿ãŒã³
3.30%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-31 äž»èŠã€ã³ãµã€ã
Aytu Biopharma Incã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå¥å
šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»è¬åæ¥çã§ã®é äœã¯155äž81äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯9.50ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžéãã¬ã³ããšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯å¹³åçã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Aytu Biopharma Incã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Aytu Biopharma Incã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Aytu Biopharma Inc ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
ææšî
ææš
売ã(1)
äžç«(3)
è²·ã(1)
ç§»åå¹³å
売ã(2)
äžç«(0)
è²·ã(4)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Aytu Biopharma Incã®äŒæ¥æ
å ±î
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
äŒæ¥ã³ãŒãAYTU
äŒæ¥åAytu Biopharma Inc
æé«çµå¶è²¬ä»»è
ãCEOãDisbrow (Joshua R)
ãŠã§ããµã€ãhttps://aytubio.com/
æ ªäž»çµ±èšî
ãããã質å
Aytu Biopharma IncïŒAYTUïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îAytu Biopharma IncïŒAYTUïŒã®çŸåšã®æ ªäŸ¡ã¯2.24ã§ãã
Aytu Biopharma Incã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îAytu Biopharma Incã®ãã£ãã«ãŒã·ã³ãã«ã¯AYTUã§ãã
Aytu Biopharma Incã®52é±é«å€ã¯ãããã§ããïŒ
îAytu Biopharma Incã®52é±é«å€ã¯3.06ã§ãã
Aytu Biopharma Incã®52é±å®å€ã¯ãããã§ããïŒ
îAytu Biopharma Incã®52é±å®å€ã¯1.46ã§ãã
Aytu Biopharma Incã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îAytu Biopharma Incã®æäŸ¡ç·é¡ã¯24.04Mã§ãã
Aytu Biopharma Inc (AYTU) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãAytu Biopharma IncïŒAYTUïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯9.50ã§ãã
Aytu Biopharma Inc (AYTU) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îAytu Biopharma IncïŒAYTUïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-2.16ã§ãã